TransMedics Group, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Waleed H. Hassanein, with a market cap of $3.8B.
Common questions about TransMedics Group, Inc.
TransMedics Group, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $174.5M.
TransMedics Group, Inc. has approximately 584 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.